India, July 16 -- Mumbai-based healthtech startup Truemeds has secured INR 174 Cr (around $20 Mn) as a part of its Series C funding round from Peak XV Partners.

As per Truemeds' MCA filings assessed by Inc42, the startup has raised the amount by allotting 19,737 Series C2 compulsory convertible preference shares (CCPS) of a face value of INR 100 each and premium of INR 88,231.

Truemeds said it would use the capital primarily towards advancing the business and facilitating the planned growth of the company. The company's post money valuation stands north of $400 Mn.

This is in addition to Truemeds' INR 375.2 Cr (about $44 Mn) funding round led by Accel India VII (Mauritius) Ltd in March. The company's board passed a resolution to allot ...